Acadia Healthcare Company Inc
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
ACHC$38.64+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Equity (Unaudited)
Condensed Consolidated Statements of Equity
(In thousands)
| Common Stock · AdditionalPaid-in · Retained | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Earnings | Total | |
| Balance at December 31, 2022 | 89,914 | $899 | $2,658,440 | $153,388 | $2,812,727 |
| Common stock issued under stock incentive plans | 1,039 | 11 | 1,192 | — | 1,203 |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (48,874) | — | (48,874) |
| Equity-based compensation expense | — | — | 7,629 | — | 7,629 |
| Other | — | — | 902 | — | 902 |
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 66,015 | 66,015 |
| Balance at March 31, 2023 | 90,953 | 910 | 2,619,289 | 219,403 | 2,839,602 |
| Common stock issued under stock incentive plans | 176 | 1 | 3,783 | — | 3,784 |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (2,017) | — | (2,017) |
| Equity-based compensation expense | — | — | 7,348 | — | 7,348 |
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 72,299 | 72,299 |
| Balance at June 30, 2023 | 91,129 | 911 | 2,628,403 | 291,702 | 2,921,016 |
| Common stock issued under stock incentive plans | 76 | 1 | 1,553 | — | 1,554 |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (843) | — | (843) |
| Equity-based compensation expense | — | — | 8,163 | — | 8,163 |
| Other | — | — | 382 | — | 382 |
| Net loss attributable to Acadia Healthcare Company, Inc. | — | — | — | (217,710) | (217,710) |
| Balance at September 30, 2023 | 91,205 | 912 | 2,637,658 | 73,992 | 2,712,562 |
| Common stock issued under stock incentive plans | 59 | 1 | 1,655 | — | 1,656 |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (798) | — | (798) |
| Equity-based compensation expense | — | — | 9,149 | — | 9,149 |
| Other | — | — | 1,676 | — | 1,676 |
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 57,729 | 57,729 |
| Balance at December 31, 2023 | 91,264 | 913 | 2,649,340 | 131,721 | 2,781,974 |
| Common stock issued under stock incentive plans | 310 | 3 | 4,099 | — | 4,102 |
| Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises | — | — | (5,115) | — | (5,115) |
| Equity-based compensation expense | — | — | 8,678 | — | 8,678 |
| Net income attributable to Acadia Healthcare Company, Inc. | — | — | — | 76,383 | 76,383 |
| Balance at March 31, 2024 | 91,574 | $916 | $2,657,002 | $208,104 | $2,866,022 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.